Tuesday, 19 October 2021

Pfizer/BioNTech Covid-19 vaccine highly protective in 12-18 age group: US CDC study

The Pfizer Inc/BioNTech SE Covid-19 vaccine was 93 per cent effective in preventing hospitalisations among those aged 12 to 18, according to an analysis released by the United States Centers for Disease Control and Prevention (CDC) on Tuesday.

Categories:

0 comments:

Post a Comment